GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Medicines Corp Ltd (SHSE:600511) » Definitions » Cash Flow for Dividends

China National Medicines (SHSE:600511) Cash Flow for Dividends : ¥-657 Mil (TTM As of Mar. 2025)


View and export this data going back to 2002. Start your Free Trial

What is China National Medicines Cash Flow for Dividends?

China National Medicines's cash flow for dividends for the three months ended in Mar. 2025 was ¥-9 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-657 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

China National Medicines's quarterly payment of dividends declined from Sep. 2024 (¥-24 Mil) to Dec. 2024 (¥47 Mil) but then increased from Dec. 2024 (¥47 Mil) to Mar. 2025 (¥-9 Mil).

China National Medicines's annual payment of dividends increased from Dec. 2022 (¥-612 Mil) to Dec. 2023 (¥-710 Mil) but then declined from Dec. 2023 (¥-710 Mil) to Dec. 2024 (¥-682 Mil).


China National Medicines Cash Flow for Dividends Historical Data

The historical data trend for China National Medicines's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Medicines Cash Flow for Dividends Chart

China National Medicines Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -613.07 -637.77 -611.96 -709.58 -682.43

China National Medicines Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -34.07 -671.01 -23.98 46.64 -8.76

China National Medicines Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-657 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China National Medicines Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of China National Medicines's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.


China National Medicines Business Description

Traded in Other Exchanges
N/A
Address
No. 8, Xibinhe Road, Floor 6-9, West Tower, 7th Floor, Yongdingmen, Dongcheng District, Beijing, CHN, 100077
China National Medicines Corp Ltd focuses on producing special drugs and high-end prescription drugs. Its main goal is to provide customers with professional medical services. The Company has one main reportable segment, the Commercial segment, which consists of the operating segment of pharmaceutical sales. Its other reportable segments consist of pharmaceutical production and logistics segments The company is also engaged in proprietary Chinese medicines, Chinese medicine decoction pieces, Chinese medicinal materials, chemical preparations, chemical raw materials, antibiotics and biochemical drugs.
Executives
Chen Zhang Qing Director

China National Medicines Headlines

No Headlines